Panel Discussion: Exploring the Bestin- Class Adjuvant to Improve Patient Response to Neoantigen Therapy

Time: 3:00 pm
day: Day Three Track A AM

Details:

  • Discussing the best approach to turn the ‘cold tumor’ into a ‘hot tumor’.
  • Outlining the variety of neoadjuvant methods to prime immune responses to neoantigen vaccination
  • Exploring the potential of a mRNA adjuvant if an mRNA vaccine platform is used for neoantigen delivery

Speakers:

Mathias Vormehr